Vimarsana
Biggest News Aggregation in the World

Fold Change News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fold Change. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fold Change Today - Breaking & Trending Today

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia - Vimarsana News

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

Despite the considerable efficacy observed when targeting a dispensable lineage antigen, such as CD19 in B cell acute lymphoblastic leukaemia1,2, the broader applicability of adoptive immunotherapies is hampered by the absence of tumour-restricted antigens3–5. Acute myeloid leukaemia immunotherapies target genes expressed by haematopoietic stem/progenitor cells (HSPCs) or differentiated myeloid cells, resulting in intolerable on-target/off-tumour toxicity. Here we show that epitope engineering of donor HSPCs used for bone marrow transplantation endows haematopoietic lineages with selecti...

Source: nature.com
Increasing lysine level improved methanol assimilation toward butyric acid production in Butyribacterium methylotrophicum | Biotechnology for Biofuels and Bioproducts - Vimarsana News

Increasing lysine level improved methanol assimilation toward butyric acid production in Butyribacterium methylotrophicum | Biotechnology for Biofuels and Bioproducts

Methanol, a promising non-food fermentation substrate, has gained increasing interest as an alternative feedstock to sugars for the bio-based production of value-added chemicals. Butyribacterium methylotrophicum, one of methylotrophic-acetogenic bacterium, is a promising host to assimilate methanol coupled with CO2 fixation for the production of organic acids, such as butyric acid. Although the methanol utilization pathway has been identified in B. methylotrophicum, little knowledge was currently known about its regulatory targets, limiting the rational engineering to improve methanol utilizat...

Related Topics:
Fold Change
Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K - Vimarsana News

Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K

January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA Disclaimers and other information Cautionary... | January 5, 2023

NWMN2330 and virulence of Staphylococcus aureus - Vimarsana News

NWMN2330 and virulence of Staphylococcus aureus

We constructed a NWMN2330 deletion mutant and a complement of S. aureus Newman to study the role of NWMN2330 in the virulence of S. aureus.

The diversity of transcriptional targets between four different coronavirus nsp1 proteins - Vimarsana News

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

Researchers investigated variations in the host immune response-elicited by non-structural protein 1 of coronaviruses.